We initially defined a set of candidate driver genes with evidence of positive selection in cancer and carried out linear modelling regressing the presence of nonsilent mutations against C-ECM-up score with cancer type as a covariate to identify genomic events that permitted adaptation to activation of the TGF-β pathway33. Here, TGFB1 is linked to cancer.